论文部分内容阅读
目的:观察喘可治注射液不同给药方式治疗支气管哮喘急性发作的临床疗效及成本-效果比。方法:将90例患者按病情分层随机分为穴位注射组、雾化吸入组、对照组3组各30例,疗程均为5天,观察临床疗效并作卫生经济学分析。结果:3组临床疗效、住院时间、住院费用分别比较,差异均无显著性意义(P>0.05),但穴位注射组和雾化吸入组口干、心跳快、肢颤发生率较对照组低,穴位注射组成本-效果比最低,经敏感性分析,穴位注射组仍低于其它2组。结论:治疗支气管哮喘急性发作,喘可治穴位注射或雾化吸入加普米克令舒雾化吸入与可必特加普米克令舒雾化吸入相比较,临床疗效、住院时间、住院费用相当,穴位注射组成本-效果比最低。
Objective: To observe the clinical curative effect and cost-effect ratio of astragalus and asthma treated by different administration methods of Chuankezhi injection. Methods: Ninety patients were randomly divided into acupoint injection group, inhalation group and control group with 30 patients in each group according to their disease stratification. The course of treatment was 5 days. The clinical curative effect was observed and analyzed by health economics. Results: There was no significant difference in the clinical efficacy, hospitalization time and hospitalization cost between the three groups (P> 0.05). However, the incidence of dry mouth, rapid heartbeat and limb tremor in the acupoint injection group and the atomized inhalation group were lower than those in the control group , Acupoint injection group cost - the effect of the lowest, by sensitivity analysis, point injection group is still lower than the other two groups. Conclusion: The treatment of acute exacerbation of bronchial asthma, asthma can be treated acupoints injection or atomization inhalation of inhalation of gatifloxacin inhalation compared with inhalation of gabprimes mbt zapatos, inhalation, clinical efficacy, hospitalization, hospitalization costs are quite, Point injection group cost - the effect of the lowest.